The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

The Health Extension for Diabetes Program is a free program that helps individuals with diabetes better manage it. The ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

At the end of 2023, more than one-third of new prescriptions to treat Type 2 diabetes were GLP-1s, such as Mounjaro and Ozempic, among others, according to a study published April 15 in Annals of ...

Scientists have long known that Type 2 diabetes patients are more prone to psychiatric and neurodegenerative disorders. The risk of developing Alzheimer's is 65% higher in diabetics. But the exact ...

Complete 36-week data for all patients is anticipated in the second quarter of 2025. UBX1325 is a novel BCL-xL inhibitor designed to eliminate senescent cells in diabetic retinal blood vessels, while ...